Search
Catalyst Pharmaceuticals Inc
CPRXAdd to Watchlist
31.380USD
-0.020-0.06%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
3.83BMarket Cap
17.37P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Catalyst Pharmaceuticals Inc is 6.40, ranking 130 out of 157 in the Pharmaceuticals industry. The average price target is 34.00, with a high of 40.00 and a low of 32.00.
Analyst Rating
Based on
4
analysts
Hold
Current Rating
32.800
Target Price
+4.53%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Catalyst Pharmaceuticals Inc
CPRX
4
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Catalyst Pharmaceuticals Inc's expected revenue for the next quarter?
Catalyst Pharmaceuticals Inc's expected revenue is 155.32M.
What is Catalyst Pharmaceuticals Inc's price target?
Analysts forecast that Catalyst Pharmaceuticals Inc's price target is USD 34.00, with the highest forecast at USD 40.00 and the lowest forecast at USD 32.00.
How have Catalyst Pharmaceuticals IncCPRX's recent earnings per share performed?
The market expectation was USD 0.52, while Catalyst Pharmaceuticals IncCPRX's earnings per share (EPS) for the previous quarter was USD 0.43. EPS for the next quarter is expected at USD 0.48.
What is the analyst rating for Catalyst Pharmaceuticals Inc?
Based on the ratings of Catalyst Pharmaceuticals Inc's stock from 4 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
